# FDA Inspection 1256835 - Taizhou Xianju Pharmaceutical Co. Ltd. - November 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/taizhou-xianju-pharmaceutical-co-ltd/4d0a9743-67dd-48f3-ad1b-78aa21302e07
Source feed: FDA_Inspections

> FDA Inspection 1256835 for Taizhou Xianju Pharmaceutical Co. Ltd. on November 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256835
- Company Name: Taizhou Xianju Pharmaceutical Co. Ltd.
- Inspection Date: 2024-11-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1256835 - 2024-11-15](https://www.keypedia.com/records/fda_inspections/taizhou-xianju-pharmaceutical-co-ltd/21e5bb94-3e39-43e0-a1fa-4b5538d0a135)
- [FDA Inspection 1009605 - 2017-03-31](https://www.keypedia.com/records/fda_inspections/taizhou-xianju-pharmaceutical-co-ltd/c928eb35-fe18-41ef-b120-6c5e93656bb3)

Company: https://www.keypedia.com/companies/taizhou-xianju-pharmaceutical-co-ltd/4b333061-9eb4-463f-9489-f78b16b0014d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c